These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Carboplatin does not prevent contralateral testicular tumors in patients with seminoma. Dieckmann KP; Matthies C; Kliesch S J Clin Oncol; 2011 Jul; 29(21):2944-5; author reply 2945-6. PubMed ID: 21670458 [No Abstract] [Full Text] [Related]
9. Carboplatin for stage I seminoma and the sword of Damocles. Loehrer PJ; Bosl GJ J Clin Oncol; 2005 Dec; 23(34):8566-9. PubMed ID: 16260692 [No Abstract] [Full Text] [Related]
10. Controversies in the management of stage I seminoma: adjuvant carboplatin revisited. Aparicio J; Terrasa J; Clin Transl Oncol; 2019 Feb; 21(2):246-247. PubMed ID: 29992462 [No Abstract] [Full Text] [Related]
11. The sword of Damocles and the treatment of stage I seminoma. Oliver T; Mead G; Mason M; Stenning S; Dieckmann K; Steiner H; De Santis M; Aparicio J; Skoneczna I; Kratzik C J Clin Oncol; 2006 Jun; 24(16):2599-600. PubMed ID: 16735720 [No Abstract] [Full Text] [Related]
12. Retrospective multicentre study of carboplatin monotherapy for clinical stage I seminoma. Steiner H; Scheiber K; Berger AP; Rein P; Hobisch A; Aufderklamm J; Pilloni S; Stoehr B; Aigner F; Fritzer A; Zangerl F BJU Int; 2011 Apr; 107(7):1074-9. PubMed ID: 21438975 [TBL] [Abstract][Full Text] [Related]
14. The treatment of stage A testicular seminoma by carboplatin monochemotherapy. Bojanić N; Mićić S; Vuksanović A; Vuković I; Janjić A Vojnosanit Pregl; 2009 Apr; 66(4):303-6. PubMed ID: 19432296 [TBL] [Abstract][Full Text] [Related]
15. An Open-label Randomized Phase 2 study of Durvalumab Alone or in Combination with Tremelimumab in Patients with Advanced Germ Cell Tumors (APACHE): Results from the First Planned Interim Analysis. Necchi A; Giannatempo P; Raggi D; Mariani L; Colecchia M; Farè E; Monopoli F; Calareso G; Ali SM; Ross JS; Chung JH; Salvioni R Eur Urol; 2019 Jan; 75(1):201-203. PubMed ID: 30243800 [No Abstract] [Full Text] [Related]
16. Late relapse of stage i seminoma following single-agent carboplatin. Raj S; Williams MV; Dixon AK; Robson J; Mazhar D Oncology; 2007; 73(5-6):419-21. PubMed ID: 18515983 [TBL] [Abstract][Full Text] [Related]
17. Clinical relevance of "late" in the management of late relapse after treatment for a germ cell tumor. Toner GC J Clin Oncol; 2008 Dec; 26(34):5502-3. PubMed ID: 18936469 [No Abstract] [Full Text] [Related]
18. Intermediate and long-term complications associated with adjuvant chemotherapy for stage I germ cell tumor patients. Suarez-Ibarrola R; Abufaraj M; Shariat SF Curr Opin Urol; 2018 Sep; 28(5):485-490. PubMed ID: 30044319 [TBL] [Abstract][Full Text] [Related]
19. [Management of localized germ-cell tumours of the testis]. Loriot Y; Fizazi K Rev Prat; 2007 Feb; 57(4):379-84. PubMed ID: 17455739 [TBL] [Abstract][Full Text] [Related]
20. Phase II study: adjuvant single-agent carboplatin therapy for clinical stage I seminoma. Krege S; Kalund G; Otto T; Goepel M; Rübben H Eur Urol; 1997; 31(4):405-7. PubMed ID: 9187898 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]